InvestorsHub Logo

davidal66

04/18/17 2:34 PM

#825 RE: gr8db8 #824

Assuming solid improvement in rGBM over Avastin... say 3 months improvement over Avastin as compared to VB-111/Avastin, how much would Roche pay to simply own the asset?